THELMA SAMPSON: Open Payments
NPI 1962882464 · SAINT CHARLES, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$589 in 38 payments from 8 companies in 2025. Trend: 2023 $229 · 2024 $202 · 2025 $589
Food & beverage: $589
| Company | Payments | Amount |
|---|---|---|
| Sequel Med Tech, LLC | 18 | $200 |
| Dexcom, Inc. | 12 | $160 |
| Medtronic, Inc. | 2 | $127 |
| Neurocrine BioSciences, Inc. | 2 | $34 |
| ABBVIE INC. | 1 | $24 |
| Abbott Laboratories | 1 | $15 |
| Rhythm Pharmaceuticals, Inc. | 1 | $15 |
| Novartis Pharmaceuticals Corporation | 1 | $14 |
Products named: TWIIST, Dexcom G6 Transmitter, MINIMED 780G, CRENESSITY, FREESTYLE LIBRE 3, IMCIVREE, LEQVIO.
Industry payments across MO — which companies pay providers there.
